Fig. 3From: Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled studyProportion of subjects with pain relief through 2 h postdoseBack to article page